Taken together, our findings suggest that aberrant upregulation of LONP1 may facilitate tumorigenesis and progression of PCa and that its expression also exerts a crucial role in predicting clinical outcomes for patients with PCa. This evidence concerns the gene LONP1 and posterior cortical atrophy.